Immune Gene Therapy and the International Conference on Lymphocyte Engineering (ICLE 2018)

Adi Barzel

doi:10.1089/hum.2018.29069.aba

Immune Gene Therapy and the International Conference on Lymphocyte Engineering (ICLE 2018)

Adi Barzel

Biochemistry Molecular Biology

Tel Aviv University

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	vii-ix
Journal	Human Gene Therapy
Volume	29
Issue number	6
DOIs	https://doi.org/10.1089/hum.2018.29069.aba
State	Published - Jun 2018

All Science Journal Classification (ASJC) codes

Genetics
Molecular Medicine
Molecular Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1089/hum.2018.29069.aba

Cite this

@article{b9a22947402a4e85a1b33078ecda30bf,

title = "Immune Gene Therapy and the International Conference on Lymphocyte Engineering (ICLE 2018)",

author = "Adi Barzel",

year = "2018",

month = jun,

doi = "10.1089/hum.2018.29069.aba",

language = "الإنجليزيّة",

volume = "29",

pages = "vii--ix",

journal = "Human Gene Therapy",

issn = "1043-0342",

publisher = "Mary Ann Liebert Inc.",

number = "6",

}

TY - JOUR

T1 - Immune Gene Therapy and the International Conference on Lymphocyte Engineering (ICLE 2018)

AU - Barzel, Adi

PY - 2018/6

Y1 - 2018/6

UR - http://www.scopus.com/inward/record.url?scp=85048667872&partnerID=8YFLogxK

U2 - 10.1089/hum.2018.29069.aba

DO - 10.1089/hum.2018.29069.aba

M3 - كلمة العدد

SN - 1043-0342

VL - 29

SP - vii-ix

JO - Human Gene Therapy

JF - Human Gene Therapy

IS - 6

ER -

Immune Gene Therapy and the International Conference on Lymphocyte Engineering (ICLE 2018)

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this